IRIS
DEL POETA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 73.738
AS - Asia 6.671
EU - Europa 6.665
SA - Sud America 1.038
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 98
OC - Oceania 20
Totale 88.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 73.434
SG - Singapore 2.929
DE - Germania 1.808
CN - Cina 1.510
UA - Ucraina 1.019
RU - Federazione Russa 935
BR - Brasile 826
IT - Italia 703
IE - Irlanda 636
HK - Hong Kong 620
VN - Vietnam 543
GB - Regno Unito 435
FR - Francia 307
BD - Bangladesh 269
SE - Svezia 261
FI - Finlandia 250
KR - Corea 219
JP - Giappone 183
CA - Canada 156
IN - India 88
NL - Olanda 73
AR - Argentina 56
PL - Polonia 53
MX - Messico 52
ZA - Sudafrica 43
TR - Turchia 38
AT - Austria 35
EC - Ecuador 34
ES - Italia 32
UZ - Uzbekistan 32
ID - Indonesia 30
PH - Filippine 28
BE - Belgio 27
CO - Colombia 25
IQ - Iraq 24
VE - Venezuela 22
JM - Giamaica 21
SA - Arabia Saudita 21
CL - Cile 20
TH - Thailandia 18
UY - Uruguay 18
AU - Australia 16
PE - Perù 16
PY - Paraguay 16
CR - Costa Rica 14
CZ - Repubblica Ceca 14
PK - Pakistan 14
MY - Malesia 10
NP - Nepal 10
CH - Svizzera 9
EU - Europa 9
IL - Israele 9
KE - Kenya 9
LT - Lituania 9
EG - Egitto 8
LB - Libano 8
MA - Marocco 8
NI - Nicaragua 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
HN - Honduras 7
JO - Giordania 7
KZ - Kazakistan 7
RO - Romania 7
SN - Senegal 7
AL - Albania 6
DK - Danimarca 6
DM - Dominica 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
EE - Estonia 6
GR - Grecia 6
GT - Guatemala 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
IR - Iran 5
KG - Kirghizistan 5
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
HR - Croazia 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
OM - Oman 4
PR - Porto Rico 4
PT - Portogallo 4
SV - El Salvador 4
AO - Angola 3
BH - Bahrain 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
GD - Grenada 2
Totale 88.214
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.018
Wilmington 17.838
Houston 15.528
Fairfield 2.049
Ann Arbor 1.727
Singapore 1.662
Ashburn 1.578
Chandler 1.132
San Jose 959
Jacksonville 921
Seattle 854
Cambridge 712
Dublin 625
Hong Kong 604
Beijing 573
Dearborn 519
Medford 466
New York 334
Santa Clara 329
The Dalles 312
Dallas 252
Council Bluffs 232
Lawrence 219
Los Angeles 208
Ho Chi Minh City 184
Zhengzhou 173
Buffalo 148
Tokyo 143
Moscow 140
Rome 137
Lauterbourg 133
Hanoi 129
Mülheim 106
San Diego 105
São Paulo 81
Milan 77
Munich 76
Chicago 74
Menlo Park 62
University Park 49
Denver 48
London 48
Phoenix 48
Hefei 46
Boardman 45
Brooklyn 45
Montreal 44
Mountain View 42
Nanjing 42
Norwalk 41
Orem 40
Redondo Beach 39
Shanghai 38
Toronto 38
Warsaw 38
Nuremberg 36
Atlanta 34
Helsinki 34
Frankfurt am Main 33
Creede 32
Falls Church 29
Johannesburg 28
Palo Alto 28
Verona 27
Kunming 26
Redwood City 26
Guangzhou 25
San Francisco 24
Brussels 23
Chennai 22
Columbus 22
Haiphong 21
Rio de Janeiro 21
Saint Augustine 21
Boston 20
Brasília 20
Naples 20
Da Nang 19
Detroit 19
Belo Horizonte 18
South Portland 18
Manchester 17
Mexico City 17
Poplar 17
Saint Petersburg 17
Wuhan 17
Amsterdam 16
Montevideo 16
Kingston 15
Nürnberg 15
Lima 14
Louisville 14
North Bergen 14
Philadelphia 14
Stockholm 14
Ankara 13
Bologna 13
Chengdu 13
Jakarta 13
Salt Lake City 13
Totale 75.038
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 652
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 568
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 550
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 547
CD7 expression in acute myeloid leukemia 540
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 534
A case of SRSF2 mutation in chronic lymphocytic leukemia 530
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 523
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0) 522
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 522
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 515
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 514
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 511
Graft failure due to hemolytic uremic syndrome recurrence 508
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes 508
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 505
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 505
Clinical significance of CD38 expression in chronic lymphocytic leukemia 503
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 501
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 498
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 494
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 492
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) 491
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 487
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 485
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 485
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance 484
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 483
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. 483
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 483
Comparison between conventional banding analysis and FISH screening with an AML specific set of probes in 260 patients 483
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia - Analysis of prognostic factors 483
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 483
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 483
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 477
Diagnosis of acute myeloid leukemia and system Coulter VCS 477
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 477
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 477
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma 475
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia 473
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 473
Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab 472
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia 471
Biological features of acute myeloid leukemia in the elderly 471
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 469
Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas 469
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura 466
In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts 462
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 460
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 459
Graft failure due to hemolytic uremic syndrome recurrence 458
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells 458
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients 456
AML-M0: a biological and clinical profile 456
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia 455
Lecam1/Icam1 ratio identifies a distinct pattern on normal and myelodysplastic bone marrow CD34+ progenitors cells 455
Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia 454
FISH analysis for CML monitoring? 454
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 454
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients 453
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. 453
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab 452
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 452
CD7 Expression in acute myeloid leukemia 451
Biological pattern of AML-M0 versus AML-M1: Response 451
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 450
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 450
Management of hematological malignancies in patients affected by renal failure 448
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 446
Molecular characterization of Ph' + hybrid acute leukemia 446
Cutaneous involvement in multiple myeloma and bortezomib 445
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 445
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 445
Clinical heterogeneity of idiopathic CD4+T lymphocytopenia 445
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 443
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 443
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 442
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 442
Pure erythroid leukemia in advanced breast cancer. 442
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 441
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping 441
Clinical implication of cytokine and soluble receptor measurements in patients with newly diagnosed aggressive non Hodgkin Lymphomas 441
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia 440
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia 438
CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target 436
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations 434
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 434
Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera 434
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 433
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 432
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 432
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) 432
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 430
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival 430
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 430
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 429
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 428
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study 428
P-glycoprotein expression in de novo acute myeloid leukemia 428
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 427
Totale 47.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.743
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.755 0 0 0 107 39 206 119 112 115 222 138 697
2022/20232.879 362 240 206 281 194 631 269 165 286 10 182 53
2023/2024875 101 35 39 15 101 297 44 29 19 11 14 170
2024/20254.519 152 1.210 582 250 61 187 400 207 411 349 314 396
2025/20267.720 680 350 1.094 630 605 305 862 944 892 692 339 327
2026/20272.627 403 347 1.436 441 0 0 0 0 0 0 0 0
Totale 88.666